XBI

Fund Description
The SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the Index ). The S&P Biotechnology Select Industry represents the biotechnology segment of the S&P Total Market Index ( S&P TMI ). The S&P TMI is designed to track the broad U.S. equity market. The biotechnology segment of the S&P TMI comprises the Biotechnology sub-industry. The Index is modified equal weighted.
Fund Profile
Fund Name SPDR S&P Biotech ETF
Fund Exchange Ticker XBI
Fund Sponsor State Street (SPDR)
Fund ISIN US78464A8707
Net Expense Ratio 0.35 %
Fund Inception Date 31 January 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name S&P Biotechnology Select Industry Index
Index Provider S&P DJ Indices
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 23 June 2022
Asset Under Management 6981.98 Million (USD)
1 Month Total Return 12.55 %
Year To Date Return -31.91 %
1 Year Total Return -45.03 %
3 Year Annualized Total Return -3.03 %
NAV 76.3267
Share Outstanding 91,475,000
Top 10 Holdings (23 June 2022)
Constituent Name Constituent Ticker Constituent Type Weighting
TWIST BIOSCIENCE CORP TWST EQUI 0.0144788700
GLOBAL BLOOD THERAPEUTICS IN GBT EQUI 0.0139054400
AMICUS THERAPEUTICS INC FOLD EQUI 0.0133182800
FATE THERAPEUTICS INC FATE EQUI 0.0131538900
NOVAVAX INC NVAX EQUI 0.0129788900
BEAM THERAPEUTICS INC BEAM EQUI 0.0127860300
SEAGEN INC SGEN EQUI 0.0126999900
IOVANCE BIOTHERAPEUTICS INC IOVA EQUI 0.0126637600
PTC THERAPEUTICS INC PTCT EQUI 0.0126329900
EDITAS MEDICINE INC EDIT EQUI 0.0123421400